Extraction of THC and its metabolites from human nail samples using ISOLUTE® SLE+ prior to UPLC-MS/MS analysis

By Biotage

For research use only. NOT for use in diagnostic procedures.
biotage-an929-figure1-structure-of-9-tetrahydrocannabinol-thc

Figure 1. Structure of Δ9-tetrahydrocannabinol (THC).

Introduction

The testing of alternative matrices in forensic and/or clinical toxicology is gaining popularity, partly due to less invasive means of collection. Matrices such as hair or nail can provide a more rounded picture of abstinence or abuse and associated timeframes.

This application note describes a procedure for sample pre-treatment and extraction of THC and its metabolites from human nail samples, using the Biotage® Lysera for matrix pulverisation, and pre-concentration of the sample prior to clean up using ISOLUTE® SLE+ supported liquid extraction.


Manual processing protocols were developed using the Biotage® Pressure+ 96 (plate format) or 48 (column format) Positive Pressure Manifolds.

This application note contains procedures optimized for both individual column format and 96-well plate format for higher throughput applications. The methodology delivers clean extracts with analyte recoveries > 70% (plate format) or > 75% (column format) with %RSD < 10% for all analytes and LLOQ as low as 20 fg/mg of nail.

ISOLUTE SLE+ Supported Liquid Extraction cartridges and plates offer an efficient alternative to traditional liquid-liquid extrac- tion (LLE) for bioanalytical sample preparation, providing high analyte recoveries, no emulsion formation and significantly reduced preparation time.

Analytes

Tetrahydrocannabinol (THC), 11-Nor-9-carboxy-Δ⁹- tetrahydrocannabinol (THC-COOH), 11-Hydroxy-Δ⁹- tetrahydrocannabinol (THC-OH), Δ9-tetrahydrocannabinolic acid-A (THCAA), cannabidiol (CBD), and cannabinol (CBN)

Internal standards

Tetrahydrocannabinol –D3 (THC- D3), 11-Nor-9-carboxy-Δ⁹- tetrahydrocannabinol-D3 (THC- COOH-D3) and 11-Hydroxy-Δ⁹- tetrahydrocannabinol- D3 (THC-OH- D3)

These were used during the calibration process and recovery work was also done alongside the standards.

Sample preparation procedure

Format

ISOLUTE® SLE+ 400 µL capacity cartridges (p/n 820-0055-B) or
ISOLUTE® SLE+ 400 µL capacity 96-well plate (p/n 820-0400-P01)

Matrix preparation

Weigh 10 mg of nail into 2 mL Biotage® Lysera tubes (p/n 19-620) containing 4 x 2.4 mm stainless steel beads (p/n 19-640).

Micropulverisation procedure

Grind to a fine powder using Biotage® Lysera (Conditions - 8 x 6.95 m/sec for 45 seconds with a 45 second dwell.)

Add 1 mL 0.1% formic acid in methanol to each nail sample. Also add 10 µL of a 10 ng/mL ISTD making a 10 pg/mg spike. Mix.

Centrifuge tubes for 10 minutes at 13,300 rpm (Heraeus Pico 17 Microcentrifuge (Thermo Scientific) with 24 position, 2 mL rotor).

Post micropulverisartion

Transfer a 250 µL aliquot of supernatant into 12 x 75 mm evaporation tubes and evaporate extracts to dryness using a TurboVap® LV at 40 °C. Reconstitute in methanol:water (80:20, v/v, 250 µL).

Supported liquid extraction conditions

 

ISOLUTE® SLE+ 400 µL Cartridges
Part Number 820-0055-B

ISOLUTE® SLE+ 400 µL Plate
Part number 820-0400-P01

Sample loading

 

 

 

 

Load up to 250 µL of reconstituted extract onto each ISOLUTE® SLE+ cartridge. A pulse of pressure is not needed as the methanolic extract flows straight onto the bed. Allow the sample to absorb for 5 minutes.

Load up to 250 µL of reconstituted extract onto each ISOLUTE® SLE+ well. A pulse of pressure is not needed as the methanolic extract flows straight onto the bed. Allow the sample to absorb for 5 minutes.

Analyte Extraction

Apply MTBE (600 µL) allow to flow under gravity for 5 minutes. Apply a further aliquot of MTBE (600 µL) and allow to flow under gravity for 5 minutes. For complete removal apply a pulse of positive pressure at 10 psi (10–20 seconds).

Apply MTBE (600 µL) allow to flow under gravity for 5 minutes. Apply a further aliquot of MTBE (600 µL) and allow to flow under gravity for 5 minutes. For complete removal apply a pulse of positive pressure at 10 psi (10–20 seconds).

Collection Vessels

Collect extract in 12 x 75 mm glass tubes.

Collect extract in 96-well collection plates.

Post Elution

Evaporate extracts at 40 °C, for 30 mins at a flow rate of 1.5 L/min using a Turbovap® LV.

Evaporate extracts at 40 °C, for 30 mins at a flow rate of 20-40 L/min using the Biotage® SPE Dry-96.

Reconstitute

Reconstitute extracts in a mix of mobile phase A/mobile phase B (80:20, v/v, 200 µL). Vortex mix, transfer into a 96-well format plate and cover with a sealing mat prior to injection.

Reconstitute extracts in a mix of mobile phase A/mobile phase B (80:20, v/v, 200 µL). Vortex mix. Cover plate with a sealing mat prior to injection.

UHPLC conditions

Instrument

Shimadzu Nexera X2 UHPLC

Column

Restek Pinnacle DB Biphenyl 1.9um 50 x 2.1 mm combined with a Restek EXP guard holder and biphenyl guard

Mobile phase

A: 0.01% Formic Acid (aq)
B: 0.01% Formic Acid in MeCN

Flow rate

0.7 mL/min

Table 1. UHPLC gradient.

Time (min)

%A

%B

0

60

40

2.5

5

95

2.6

60

40

4.1

60

40

Injection volume

5 µL

Column temperature

50 °C

MS/MS conditions

Instrument

Shimadzu 8060 Triple Quadrupole MS using ES interface

Nebulizing gas flow

3 L/min

Drying gas flow

5 L/min

Heating gas flow

15 L/min

Interface temperature

400 oC

DL temperature

300 oC

Heat block temperature

500 oC

CID gas flow

270 kPa

Table 2. MS conditions for target analytes in positive mode.

Analytes

MRM Transition

Collision Energy

THC-D3

318.0 > 196.15

-24

318.0 > 123.2

-32

THC

315.0 > 193.10

-23

315.0 > 123.2

-32

OH-THC-D3

334.0 > 316.15

-15

334.0 > 196.25

-25

OH-THC

331.0 > 313.3

-15

331.0 > 193.25

-26

THC-COOH-D3

346.3 > 302.3

22

346.3 > 248.30

28

THC-COOH

343.3 > 299.3

22

343.3 > 245.25

30

CBN

309.3 > 279.1

32

309.3 > 222.05

47

CBD

315.1 > 193.1

-23

315.1 > 123.25

-35

THCAA

357.3 > 313.3

26

357.3 > 245.25

33

Results

This simple sample preparation method delivers clean extracts and analyte recoveries mostly greater than 75% with RSDs lower than 10% for all analytes (see fig 2). LLOQs are below 10 pg/mg and as low as 20 fg/mg for THCA-A (see table 3) for ISOLUTE® SLE+ cartridge formats used.

Recoveries

biotage-an929-figure2-representative-analyte-recoveriesFigure 2. Representative analyte recoveries.

Calibration curves

biotage-an929-figure3-calibration-curvesFigure 3. Calibration curves for THC (a), CBN (b) and THCA-A (c) using human nail with 400 µL capacity cartridge format (loading 250 µL of extracted sample as described).

Calibration curve performance was investigated from nails spiked between 0.01–100 pg/mg. Good linearity was observed for all analytes typically delivering r2 values greater than 0.999. Table 3. details linearity performance and associated LOQ for each analyte using both ISOLUTE® SLE+ formats.

Table 3. Analyte calibration curve r2 and LOQ performance.

Analyte

r2

LLOQ (pg/mg)

r2

LLOQ (pg/mg)

 

Column Format

Plate Format

THC

0.9997

5

0.9998

10

OH-THC

0.9997

5

0.9998

10

THC-COOH

0.9995

1

0.9997

1

CBN

0.9995

1

0.9992

1

CBD

0.9992

1

0.9992

1

THCAA

0.9995

0.02

0.9997

0.05

Chemicals and reagents

  • Methanol (LC-MS grade), Acetonitrile (Gradient MS) were purchased from Honeywell Research Chemicals (Bucharest, Romania).
  • All analyte standards and deuterated internal standards, and acetic acid (99.7%) (LC-MS grade) were purchased from Sigma-Aldrich Company Ltd. (Gillingham, UK).
  • Water used was 18.2 MOhm-cm, drawn daily from a Direct-Q5 water purifier.
  • Mobile phase A (0.01% Formic acid aq) was prepared by adding 50 µL acid to 500 mL of purified water.
  • Mobile phase B (0.01% Formic acid in acetonitrile) was prepared by adding 50 µL acid to 500 mL of HPLC grade acetonitrile.
  • Internal standards (10 pg/mg) were prepared from a 1 ng/µL stock solution by adding 10 µL of each of to 970 µL of MeOH. This makes a 10 ng/mL stock and then 10 µL of this solution was added to each calibration sample.

Additional information

  • All data shown in this application note was generated using various fingernail samples, provided by healthy human volunteers.
  • THC and some of its metabolites bind to plastic, so in order to increase recoveries and reduce RSDs the pre-concentration evaporation steps should always be performed in glass tubes.
  • Biotage®Lysera hints and tips
    • A minimum of four tubes must be loaded in the tube carriage to ensure balance during processing.
    • Ensure vial caps are firmly tightened and Lysera locking mechanism is fully engaged.
    • To minimize sample transfer and manipulation steps, 2 mL Lysera tubes were placed directly into the centrifuge (Heraeus Pico 17 Microcentrifuge (Thermo Scientific) with 24 position, 2 mL rotor).

Conclusion

This application note demonstrates that ISOLUTE®SLE+ cartridges or plates can be used in conjunction with Biotage® Lysera to provide a simple but effective sample preparation procedure for determination of THC and metabolites from human nail samples.

Ordering information

Part Number

Description

Quantity

19-060

Biotage® Lysera

1

19-649

2 mL Reinforced Tubes with Screw Caps (Bulk pack)

1000

19-640

2.4 mm Metal Beads 500 grams

1

820-0055-B

ISOLUTE 400 µL Sample Volume Cartridges

50

820-0400-P01

ISOLUTE SLE+ 400 µL Capacity Plate

1

PPM-96

Biotage® PRESSURE+ 96 Positive Pressure Manifold

1

PPM-48

Biotage® PRESSURE+ 48 Positive Pressure Manifold

1

415000

TurboVap® LV

1

SD-9600-DHS-EU

Biotage® SPE Dry 96 Sample Concentrator system 220/240V

1

SD-9600-DHS-NA

Biotage® SPE Dry 96 Sample Concentrator system 100/120V

1

121-5203

Collection Plate, 2 mL Square

50

121-5204

Piercable Sealing Mat

50

C44651

Test Tubes (12 x 75 mm, Uncap)

1000

 

 

Literature Number: AN929

Published: Dec 7, 2025 6:00:00 AM

Related literature